查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2048021

消融導管市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、最終用途、地區和競爭格局分類，2021-2031年

Ablation Catheters Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Radiofrequency Ablation, Cryoablation, Pulse Field Ablation), By End Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 177 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球消融導管市場預計將從 2025 年的 48.7 億美元大幅成長至 2031 年的 84.7 億美元，複合年成長率為 9.66%。

這些專用醫療設備利用射頻和低溫等多種能量形式，精準靶向並阻斷導致心律不整的心臟組織異常電訊號。推動這一成長的關鍵因素包括全球心血管疾病發病率的上升以及人口老化，老年人更容易出現心率。此外，與傳統開胸手術相比，微創手術技術能夠加速患者康復，其日益成長的需求也促進了這些產品的廣泛應用。美國心臟協會 (AHA) 在 2025 年報告中預測，到 2030 年，將有超過 1,200 萬美國人患有心房顫動，凸顯了對有效治療方法的迫切需求。

市場概覽
預測期 2027-2031
市場規模：2025年 48.7億美元
市場規模：2031年 84.7億美元
複合年成長率：2026-2031年 9.66%
成長最快的細分市場 射頻消融術
最大的市場 北美洲

儘管對消融導管的需求依然強勁，但市場仍存在諸多障礙。這些障礙包括先進導管技術的高昂成本以及複雜且因地區而異的報銷制度。這些經濟障礙往往限制了醫院的購買力，阻礙了病人獲得必要的治療。在醫療設備預算有限的開發中國家，這種情況尤其突出。因此，經濟限制仍然是消融療法在全球推廣和普及的主要障礙。

市場促進因素

脈衝電場​​消融 (PFA) 技術正迅速崛起，成為一項極具創新性的技術，其快速普及正在深刻改變產業格局。與可能損傷鄰近組織的傳統熱能消融方法不同，PFA 利用非熱能電場精確消融心肌細胞，從而顯著提升了安全性和效率，使其對電生理學家極具吸引力。隨著醫療機構加大對支持這些先進平台系統的投資，這項突破性創新正在迅速改變醫院的採購模式。 2025 年 10 月，《生物世界》(BioWorld) 發表了一篇題為「波士頓科學公司 Farapulse 和 Watchman 推動第三季度業績成長」的報導，重點介紹了波士頓科學公司電生理部門銷售額成長 63% 的情況，這主要得益於其 Farapulse脈衝電場消融系統在全球範圍內的快速普及。這項迅速的商業性成功凸顯了該技術在擴大市場收入和重塑主要醫療設備製造商之間的競爭格局方面所發揮的關鍵作用。

心房顫動和其他心律不整發病率的不斷上升是推動全球治療人數持續成長的根本因素。隨著全球人口老化和高血壓等合併症盛行率的上升，需要治療性介入的患者總數不斷增加，給醫療保健系統提供有效的心律不整管理方案帶來了巨大壓力。 2025年2月，山景城地區醫療中心報告稱，美國心房顫動的預計患病人數將至少達到1,050萬成年人，凸顯了擴充性治療方法的緊迫性。不斷成長的患者需求正直接影響臨床方法和技術選擇。 2025年MedTech Dive的一項調查預測，到2026年，脈衝電場消融將佔所有心房顫動消融手術的68%，這表明市場正在轉向更高效的治療方法。

市場挑戰

由於先進導管技術高成本且報銷機制複雜，全球消融導管市場面臨大幅擴張的重大障礙。醫療機構和醫院的預算普遍緊張，因此購買昂貴的尖端消融設備是一筆龐大的資本支出。當公共和私人保險公司的報銷額不足以涵蓋這些高昂的採購成本時，醫療機構往往被迫限制庫存或推遲新技術的引進。這種資金缺口最終限制了患者獲得最有效治療的機會，尤其是在醫療資金本就捉襟見肘的地區。

近期降低醫療服務提供者報酬的政策變化加劇了經濟壓力，直接影響了醫院的購買力。例如，美國心臟學會2024年指出，美國醫療保險和醫療補助服務中心（CMS）已最終確定，2025年醫師報銷的轉換率將降低2.83%。此類報銷額的降低削弱了進行複雜心血管手術的經濟可行性。因此，儘管臨床需求不斷成長，但這些財務困境阻礙了先進消融療法的廣泛應用，並抑制了整體市場成長。

市場趨勢

將人工智慧 (AI) 整合到 3D 標測和導航系統中，透過對複雜心電圖的即時分析，從根本上改變了心導管電氣燒灼術的精確度。先進的 AI 演算法使電生理學家能夠準確識別關鍵的消融靶點，例如心房顫動的終止部位，而這些標靶僅靠傳統標測技術難以精確定位。這項技術進步不僅縮短了手術時間，而且透過根據患者的解剖結構和電活動最佳化治療方案，顯著提高了長期臨床成功率。根據發表在 2025 年 5 月《心臟節律新聞》(Cardiac Rhythm News) 上題為“HRS 2025 研究凸顯 AI 在改善心導管電氣燒灼術技術方面的報導”的文章，一項使用 AI 驅動的 DeePRISM 模型的研究表明，患者獲得了更佳的長期療效，高達 70% 的患者在兩年的時間復發期間避免了心律失常的隨訪期間。

同時，心導管電氣燒灼術市場正經歷著從醫院住院部向門診手術中心（ASC）的顯著轉變，這主要得益於檢驗的安全方案，這些方案使得患者能夠當日出院。隨著醫療保險公司和醫療機構努力降低醫療成本並最佳化床位利用率，門診工作流程的有效性已得到證實，這使得常規病例更容易轉移到這些更有效率、風險更低的場所進行治療。臨床證據表明，絕大多數患者無需住院過夜即可安全接受消融手術，這為上述轉變提供了支持。 2025年6月發表在Medscape上的一篇報導《房顫消融術當日出院標準概述》引用了一項綜合分析，該分析顯示，85%的受評估患者合格當日出院的條件，凸顯了門診手術部門手術量大幅成長的巨大潛力。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球消融導管市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 消融類型（射頻消融、冷凍消融、脈衝電場消融）
    • 依用途（住院設施、門診設施、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美消融導管市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲消融導管市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區消融導管市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東與非洲消融導管市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲消融導管市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球消融導管市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Biosense Webster, Inc.
  • Medtronic plc
  • Biotronik SE & Co. KG
  • Imricor
  • CardioFocus
  • MicroPort Scientific Corporation
  • Integer Holdings Corporation
  • jMedtech Coating Technologies Pte Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 25350

The global market for ablation catheters is projected to expand significantly, rising from USD 4.87 billion in 2025 to USD 8.47 billion by 2031, demonstrating a compound annual growth rate (CAGR) of 9.66%. These specialized medical devices use various energy forms, like radiofrequency or cryothermal waves, to precisely target and disrupt abnormal electrical signals in cardiac tissue responsible for arrhythmias. Key factors driving this growth include the increasing global incidence of cardiovascular diseases and an aging population, which is more prone to heart rhythm disorders. Furthermore, the growing preference for minimally invasive surgical methods enhances adoption, as these procedures offer quicker patient recovery compared to traditional open-heart surgeries. The American Heart Association reported in 2025 that atrial fibrillation is expected to impact over 12 million Americans by 2030, highlighting a substantial and increasing need for effective treatments.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 4.87 Billion
Market Size 2031USD 8.47 Billion
CAGR 2026-20319.66%
Fastest Growing SegmentRadiofrequency (RF) Ablation
Largest MarketNorth America

While demand for ablation catheters is strong, the market encounters notable obstacles, particularly the high expenses linked with advanced catheter technologies and the intricate reimbursement systems prevalent across different regions. Such financial hurdles frequently restrict hospital purchasing power and hinder patient access to essential treatments, especially in healthcare systems within developing nations where resources for costly medical devices are limited. As a result, economic constraints persist as a major impediment to the widespread global adoption and expansion of ablation therapies.

Market Driver

Pulsed Field Ablation (PFA) technologies are emerging as a highly disruptive force, significantly transforming the industry landscape through their rapid adoption. Unlike conventional thermal energy methods that can damage adjacent tissues, PFA employs non-thermal electrical fields to precisely ablate cardiac cells, providing enhanced safety and efficiency that is particularly attractive to electrophysiologists. This groundbreaking innovation has prompted a swift change in hospital purchasing patterns, as facilities increasingly invest in systems compatible with these advanced platforms. A BioWorld article from October 2025, titled 'Boston Sci Farapulse, Watchman boost Q3 performance,' highlighted Boston Scientific's 63% revenue increase in its electrophysiology division, largely attributed to the accelerated global embrace of its Farapulse pulsed field ablation system. This rapid commercial success underscores the technology's critical role in boosting market revenue and redefining competition among leading medical device manufacturers.

The increasing incidence of atrial fibrillation and other cardiac arrhythmias is a fundamental factor fueling the continuous global growth in procedural volumes. With an aging global population and the rising prevalence of co-existing conditions like hypertension, the overall number of individuals needing therapeutic intervention is growing, putting immense pressure on healthcare systems to deliver effective rhythm management solutions. MountainView Regional Medical Center reported in February 2025 that the estimated national prevalence of atrial fibrillation has reached at least 10.5 million adults, emphasizing an urgent requirement for scalable treatment options. This escalating patient demand is directly influencing clinical approaches and technology preferences; a 2025 MedTech Dive survey indicated that pulsed field ablation is anticipated to constitute 68% of all atrial fibrillation ablation procedures by 2026, signaling a market-wide shift towards more efficient therapeutic modalities.

Market Challenge

The global ablation catheters market faces significant expansion hurdles due to the elevated cost of advanced catheter technologies and the intricate reimbursement structures. Healthcare providers and hospitals operate within strict budgetary limits, making the purchase of costly, cutting-edge ablation devices a substantial capital commitment. When public and private payer reimbursement rates do not adequately cover these high procurement expenses, medical institutions often must restrict their inventory or postpone adopting newer technologies. This financial misalignment ultimately limits patient access to the most effective treatments, especially in areas with already constrained healthcare funding.

Economic pressures are exacerbated by recent policy changes that decrease provider compensation, directly affecting hospitals' purchasing capabilities. For instance, the American College of Cardiology noted in 2024 that the Centers for Medicare and Medicaid Services finalized a 2.83 percent reduction in the conversion factor for the 2025 Physician Fee Schedule. Such decreases in reimbursement undermine the financial feasibility of performing intricate cardiac procedures. These fiscal difficulties, therefore, hinder overall market growth by discouraging the broad adoption of advanced ablation therapies, despite increasing clinical necessity.

Market Trends

Artificial Intelligence (AI) integration into 3D mapping and navigation systems is fundamentally transforming the precision of cardiac ablation through real-time analysis of intricate electrograms. Sophisticated AI algorithms empower electrophysiologists to pinpoint crucial ablation targets, such as atrial fibrillation termination sites, which were previously challenging to identify using conventional mapping techniques alone. This technological advancement not only shortens procedure durations but also substantially enhances long-term clinical success by customizing treatments to individual patient anatomy and electrical activity. As reported by Cardiac Rhythm News in May 2025, in an article titled 'Research unveiled at HRS 2025 highlights AI's ability to enhance cardiac ablation procedures,' a study involving the AI-powered DeePRISM model revealed that patients achieved superior long-term results, with up to 70% remaining free from atrial arrhythmias over a two-year follow-up.

Concurrently, the market is experiencing a significant transition in cardiac ablation procedures, moving from hospital inpatient settings to Ambulatory Surgical Centers (ASCs), primarily due to validated safety protocols that support same-day discharge. With payers and providers aiming to lower healthcare costs and optimize bed utilization, the proven efficacy of outpatient workflows has facilitated the shift of routine cases to these more efficient, lower-acuity environments. This shift is substantiated by clinical evidence confirming that a large majority of patients can safely undergo ablation without requiring an overnight hospital stay. A Medscape article from June 2025, 'Same-Day Discharge Criteria Outlined for AF Ablation,' cited a comprehensive analysis indicating that 85% of assessed patients were suitable candidates for same-day discharge, emphasizing the considerable potential for increased procedure volume within the ambulatory surgical sector.

Key Market Players

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Biosense Webster, Inc.
  • Medtronic plc
  • Biotronik SE & Co. KG
  • Imricor
  • CardioFocus
  • MicroPort Scientific Corporation
  • Integer Holdings Corporation
  • jMedtech Coating Technologies Pte Ltd.

Report Scope

In this report, the Global Ablation Catheters Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Ablation Catheters Market, By Type

  • Radiofrequency (RF) Ablation
  • Cryoablation
  • Pulse Field Ablation

Ablation Catheters Market, By End Use

  • Inpatient Facilities
  • Outpatient Facilities
  • Others

Ablation Catheters Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Ablation Catheters Market.

Available Customizations:

Global Ablation Catheters Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Ablation Catheters Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Radiofrequency (RF) Ablation, Cryoablation, Pulse Field Ablation)
    • 5.2.2. By End Use (Inpatient Facilities, Outpatient Facilities, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Ablation Catheters Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Ablation Catheters Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By End Use
    • 6.3.2. Canada Ablation Catheters Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By End Use
    • 6.3.3. Mexico Ablation Catheters Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End Use

7. Europe Ablation Catheters Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Ablation Catheters Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End Use
    • 7.3.2. France Ablation Catheters Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Ablation Catheters Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Ablation Catheters Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Ablation Catheters Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By End Use

8. Asia Pacific Ablation Catheters Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Ablation Catheters Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Ablation Catheters Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End Use
    • 8.3.3. Japan Ablation Catheters Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End Use
    • 8.3.4. South Korea Ablation Catheters Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Ablation Catheters Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By End Use

9. Middle East & Africa Ablation Catheters Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Ablation Catheters Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End Use
    • 9.3.2. UAE Ablation Catheters Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End Use
    • 9.3.3. South Africa Ablation Catheters Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End Use

10. South America Ablation Catheters Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Ablation Catheters Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By End Use
    • 10.3.2. Colombia Ablation Catheters Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By End Use
    • 10.3.3. Argentina Ablation Catheters Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Ablation Catheters Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott Laboratories
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Boston Scientific Corporation
  • 15.3. Biosense Webster, Inc.
  • 15.4. Medtronic plc
  • 15.5. Biotronik SE & Co. KG
  • 15.6. Imricor
  • 15.7. CardioFocus
  • 15.8. MicroPort Scientific Corporation
  • 15.9. Integer Holdings Corporation
  • 15.10. jMedtech Coating Technologies Pte Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer